European Union - English - EMA (European Medicines Agency)

biosimilar collaborations ireland limited - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antineoplastic agents - abevmy in combination with fluoropyrimidine-based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum.abevmy in combination with paclitaxel is indicated for first-line treatment of adult patients with metastatic breast cancer. for further information as to human epidermal growth factor receptor 2 (her2) status, please refer to section 5.1.abevmy in combination with capecitabine is indicated for first-line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate. patients who have received taxane and anthracycline containing regimens in the adjuvant setting within the last 12 months should be excluded from treatment with abevmy in combination with capecitabine. for further information as to her2 status, please refer to section 5.1.abevmy, in addition to platinum-based chemotherapy, is indicated for first-line treatment of adult patients with unresectable advanced, metastatic or recurrent non-small cell lung cancer other than predominantly squamous cell histology.abevmy, in combination with erlotinib, is indicated for first-line treatment of adult patients with unresectable advanced, metastatic or recurrent non-squamous non-small cell lung cancer with epidermal growth factor receptor (egfr) activating mutations (see section 5.1).abevmy in combination with interferon alfa-2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer.abevmy, in combination with carboplatin and paclitaxel is indicated for the front-line treatment of adult patients with advanced (international federation of gynecology and obstetrics [figo] stages iii b, iii c and iv) epithelial ovarian, fallopian tube, or primary peritoneal cancer (see section 5.1).abevmy, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum-sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor–targeted agents.abevmy in combination with paclitaxel, topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum-resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor–targeted agents (see section 5.1).abevmy, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, is indicated for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix (see section 5.1).

Singapore - English - HSA (Health Sciences Authority)

biomedix singapore pte. ltd. - clinical chemistry - reagent for the measurement of beta-hydroxybutyrate concentration in human serum or plasma. this reagent is for use with biosystems analyzers. for in vitro professional use only in the clinical laboratory

Singapore - English - HSA (Health Sciences Authority)

johnson & johnson pte ltd - cardiovascular - the biosense webster qdot micro uni-directional and bi-directional navigation catheter and related accessory devices are indicated for catheter-based cardiac electrophysiological mapping (stimulating and recording) and, when used in conjunction with a compatible radiofrequency generator, for cardiac ablation. the biosense webster qdot micro uni-directional and bi-directional navigation catheter provide a real-time measurement of temperature and contact force between the catheter tip and heart wall, as well as location information when used with the carto 3 system.

Australia - English - Department of Health (Therapeutic Goods Administration)

smith & nephew pty ltd - 45061 - fixation anchor, soft-tissue, biodegradable - the smith & nephew biosure? regenesorb interference screw is an absorbable biocomposite interference screw with open lateral surface area for use in the fixation of ligament, tendon, soft tissue, or bone-tendon-bone repairs in knee procedures. the biosure regenesorb interference screw is indicated for the reattachment of ligament, tendon, soft tissue, or bone-tendon-bone grafts.

Australia - English - Department of Health (Therapeutic Goods Administration)

soul pattinson manufacturing pty ltd - glucosamine sulfate potassium chloride, quantity: 995 mg (equivalent: glucosamine sulfate, qty 750 mg; equivalent: potassium chloride, qty 245 mg); bovine sodium chondroitin sulfate, quantity: 200 mg; dimethyl sulfone, quantity: 100 mg - capsule, hard - excipient ingredients: microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; silicon dioxide; titanium dioxide; sorbitan monolaurate; potable water; gelatin; sodium lauryl sulfate - helps maintain/supports healthy joint cartilage growth/development/production ; maintain/support joint health ; maintain/support joint mobility/flexibility

Australia - English - Department of Health (Therapeutic Goods Administration)

soul pattinson manufacturing pty ltd - allium sativum, quantity: 166.67 mg (equivalent: allium sativum, qty 2 g); ascorbic acid, quantity: 50 mg; sambucus nigra, quantity: 28.57 mg (equivalent: sambucus nigra, qty 200 mg); olea europaea, quantity: 200 mg (equivalent: olea europaea, qty 3.6 g); echinacea purpurea, quantity: 22.22 mg (equivalent: echinacea purpurea, qty 1 g); zinc citrate dihydrate, quantity: 15.56 mg (equivalent: zinc, qty 5 mg); handroanthus impetiginosus, quantity: 50 mg (equivalent: handroanthus impetiginosus, qty 200 mg) - capsule, hard - excipient ingredients: maltodextrin; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; titanium dioxide; purified water; gelatin; sodium lauryl sulfate - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; traditionally used in western herbal medicine to sudorific/diaphoretic/enhance/promote sweating/perspiration ; maintain/support general health and wellbeing ; maintain/support immune system health ; maintain/support healthy immune system function ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; traditionally used in western herbal medicine to expectorant/clear respiratory tract mucous ; traditionally used in western herbal medicine to relieve symptoms of mild upper respiratory tract infections ; traditionally used in western herbal medicine to decrease/reduce/relieve symptoms of common cold ; maintain/support wound healing

Australia - English - Department of Health (Therapeutic Goods Administration)

soul pattinson manufacturing pty ltd - curcuma longa, quantity: 632 mg (equivalent: curcuma longa, qty 15.8 g); piper nigrum, quantity: 5 mg (equivalent: piper nigrum, qty 100 mg) - capsule, hard - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; maltodextrin; magnesium stearate; purified water; gelatin; sodium lauryl sulfate - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support general health and wellbeing ; anti-inflammatory/relieve inflammation ; decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis (linked indication:decrease/reduce/relieve mild joint aches and pains; decrease/reduce/relieve mild joint inflammation/swelling; decrease/reduce/relieve mild joint pain/soreness)

Australia - English - Department of Health (Therapeutic Goods Administration)

soul pattinson manufacturing pty ltd - lysine hydrochloride, quantity: 624.77 mg (equivalent: lysine, qty 500 mg) - capsule, hard - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; titanium dioxide; purified water; gelatin; sodium lauryl sulfate - maintain/support collagen formation ; maintain/support energy production ; maintain/support general health and wellbeing ; aid/assist/helps protein synthesis in the body ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; helps reduce occurrence of facial cold sores

Australia - English - Department of Health (Therapeutic Goods Administration)

soul pattinson manufacturing pty ltd - magnesium amino acid chelate, quantity: 775 mg (equivalent: magnesium, qty 155 mg) - capsule, hard - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; hypromellose; disodium edetate; potable water; potassium acetate; gellan gum - maintain/support energy levels ; maintain/support energy production ; maintain/support body electrolyte balance ; maintain/support general health and wellbeing ; maintain/support healthy teeth ; maintain/support bone health ; maintain/support cardiovascular system health ; maintain/support healthy cardiovascular system function ; maintain/support heart health ; maintain/support healthy immune system function ; maintain/support muscle function ; maintain/support healthy neuromuscular system/function ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; maintain/support nerve conduction ; maintain/support nervous system health ; maintain/support nervous system function

Australia - English - Department of Health (Therapeutic Goods Administration)

soul pattinson manufacturing pty ltd - ferrous fumarate, quantity: 15.2 mg (equivalent: iron, qty 5 mg); silybum marianum, quantity: 14.29 mg (equivalent: silybum marianum, qty 1 g); biotin, quantity: 2.6 mg; zinc gluconate, quantity: 104.9 mg (equivalent: zinc, qty 15 mg); calcium ascorbate dihydrate, quantity: 60.87 mg (equivalent: ascorbic acid, qty 50 mg); vitis vinifera, quantity: 41.67 mg (equivalent: vitis vinifera, qty 5 g); silicon dioxide, quantity: 85.56 mg (equivalent: silicon, qty 40 mg); riboflavin, quantity: 1 mg - capsule, hard - excipient ingredients: maltodextrin; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; mono- and di- glycerides; titanium dioxide; purified water; gelatin; sodium lauryl sulfate - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support collagen formation ; maintain/support collagen health ; maintain/support general health and wellbeing ; maintain/support hair growth ; maintain/support hair health ; decrease/reduce nail brittleness/splitting/chipping ; aid/assist nail growth ; maintain/support nail health/strength/thickness ; enhance/improve/promote/increase nail health/strength/thickness ; maintain/support connective tissue health ; aid/assist/helps connective tissue production/formation ; maintain/support immune system health ; maintain/support healthy immune system function ; aid/assist/helps protein synthesis in the body ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; maintain/support skin health ; maintain/support skin integrity/structure ; maintain/support skin regeneration ; maintain/support wound healing